Novel Process for the Preparation of Hexacyclic Compounds
申请人:FUKUDA HIROSHI
公开号:US20090312554A1
公开(公告)日:2009-12-17
This invention relates to novel processes for the preparation of compounds of the formula [1],
wherein R
1
, R
2
, R
3
and R
4
are as defined in the claims and description as well as pharmaceutically acceptable salts thereof. The compounds of the formula [
1
] are hexacyclic compounds having potent anti-tumor activity.
Compounds and compositions are provided for treatment or amelioration of one or more symptoms of α-synuclein toxicity, α-synuclein mediated diseases or diseases in which α-synuclein fibrils are a symptom or cause of the disease.
5,6-BICYCLIC HETEROARYL-CONTAINING UREA COMPOUNDS AS KINASE INHIBITORS
申请人:Jiang Shan
公开号:US20120122895A1
公开(公告)日:2012-05-17
The present invention provides 5,6-bicyclic heteroaryl-containing urea compounds of Formula I or II and use of the same for treating conditions mediated by protein kinase such as VEGFR2, c-Met, PDGFRβ c-Kit, CSF1R, or EphA2.